MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B

Journal of Clinical Investigation

Volumn 103, Issue 6, 1999, Pages 773-778

  Gosling, Jennifa ^a   Slaymaker, Sarah ^a   Gu, Long ^b   Tseng, Susan ^b   Zlot, Constance H ^a   Young, Stephen G ^a,c,d   Rollins, Barrett J ^b   Charo, Israel F ^a,c,d  

^a GLADSTONE INSTITUTE OF CARDIOVASCULAR DISEASE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; LOW DENSITY LIPOPROTEIN RECEPTOR; MONOCYTE CHEMOTACTIC PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ATHEROGENESIS; ATHEROSCLEROSIS; DISEASE PREDISPOSITION; GENE OVEREXPRESSION; HUMAN; LIPOPROTEIN METABOLISM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; TRANSGENIC MOUSE;

EID: 0033559691     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI5624     Document Type: Review

References (46)

1. Ross, R. 1995. Cell biology of atherosclerosis. Annu. Rev. Physiol. 57:791-804.
2. Gerrity, R.G. 1981. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am. J. Pathol. 103:181-190.
3. Faggiotto, A., Ross, R., and Harker, L. 1984. Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis. 4:323-340.
4. Rollins, B.J. 1997. Chemokines. Blood. 90:909-928.
5. Cushing, S.D., et al. 1990. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells. Proc. Natl. Acad. Sci. USA. 87:5134-5138.
6. Nelken, N.A., Coughlin, S.R., Gordon, D., and Wilcox, J.N. 1991. Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Invest. 88:1121-1127.
7. Ylä-Herttuala, S., et al. 1991. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 88:5252-5256.
8. Yu, X., et al. 1992. Elevated expression of monocyte chemoattractant protein 1 by vascular smooth muscle cells in hypercholesterolemic primates. Proc. Natl. Acad. Sci. USA. 89:6953-6957.
9. Piedrahita, J.A., Zhang, S.H., Hagaman, J.R., Oliver, P.M., and Maeda, N. 1992. Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. Proc. Natl. Acad. Sci. USA. 89:4471-4475.
10. Plump, A. S., et al. 1992. Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells. Cell. 71:343-353.
11. Boring, L., Gosling, J., Cleary, M., and Charo, I.F. 1998. Decreased lesion formation in CCR2 mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:894-897.
12. Ishibashi, S., et al. 1993. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J. Clin. Invest. 92:883-893.
13. Ishibashi, S., Goldstein, J.L., Brown, M.S., Herz, J., and Burns, D.K. 1994. Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. J. Clin. Invest. 93:1885-1893.
14. Gu, L. et al. 1998. Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol. Cell. 2:275-281.
15. Linton, M.F., et al. 1993. Transgenic mice expressing high plasma concentrations of human apolipoprotein B100 and lipoprotein(a). J. Clin. Invest. 92:3029-3037.
16. Purcell-Huynh, D.A., et al. 1995. Transgenic mice expressing high levels of human apolipoprotein B develop severe atherosclerotic lesions in response to a high-fat diet. J. Clin. Invest. 95:2246-2257.
17. Kim, E., and Young, S.G. 1998. Genetically modified mice for the study of apolipoprotein B. J. Lipid Res. 39:703-723.
18. Nishina, P.M., Versruyft, J., and Paigen, B. 1990. Synthetic low and high fat diets for the study of atherosclerosis in the mouse. J. Lipid Res. 31:859-869.
19. Farese, R.V. Jr., Ruland, S.L., Flynn, L.M., Stokowski, R.P., and Young, S.G. 1995. Knockout of the mouse apolipoprotein B gene results in embryonic lethality in homozygotes and protection against diet-induced hypercholesterolemia in heterozygotes. Proc. Natl. Acad. Sci. USA. 92:1774-1778.
20. Young, S.G., Smith, R.S., Hogle, D.M., Curtiss, L.K., and Witztum, J.L. 1986. Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B. Clin. Chem. 32:1484-1490.
21. Young, S.G., Bertics, S.J., Curtiss, L.K., Casal, D.C., and Witztum, J.L. 1986. Monoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein B. Proc. Natl. Acad. Sci. USA. 83:1101-1105.
22. Young, S.G., Witztum, J.L., Casal, D.C., Curtiss, L.K., and Bernstein, S. 1986. Conservation of the low density lipoprotein receptor-binding domain of apoprotein B: demonstration by a new monoclonal antibody, MB47. Arteriosclerosis. 6:178-188.
23. Zlot, C.H., et al. 1999. Generation of monoclonal antibodies specific for mouse apolipoprotein B-100 in apolipoprotein B-48-only mice. J. Lipid Res. 40:76-84.
24. Raabe, M., et al. 1998. Knockout of the abetalipoproteinemia gene in mice: reduced lipoprotein secretion in heterozygotes and embryonic lethality in homozygotes. Proc. Natl. Acad. Sci. USA. 95:8686-8691.
25. Kim, E., Lowenson, J.D., MacLaren, D.C., Clarke, S., and Young, S.G. 1997. Deficiency of a protein-repair enzyme results in the accumulation of altered proteins, retardation of growth, and fatal seizures in mice. Proc. Natl. Acad. Sci. USA. 94:6132-6137.
26. Kim, E., Cham, C.M., Véniant, M.M., Ambroziak, P., and Young, S.G. 1998. Dual mechanisms for the low plasma levels of truncated apolipoprotein B proteins in familial hypobetalipoproteinemia: analysis of a new mouse model with a nonsense mutation in the Apob gene. J. Clin. Invest. 101:1468-1477.
27. Véniant, M.M., et al. 1997. Susceptibility to atherosclerosis in mice expressing exclusively apolipoprotein B48 or apolipoprotein B100. J. Clin. Invest. 100:180-188.
28. Rubin, E.M., Ishida, B.Y., Clift, S.M., and Krauss, R.M. 1991. Expression of human apolipoprotein A-I in transgenic mice results in reduced plasma levels of murine apolipoprotein A-I and the appearance of two new high density lipoprotein size subclasses. Proc. Natl. Acad. Sci. USA. 88:434-438.
29. Paszty, C., Maeda, N., Verstuyft, and Rubin, E.M. 1994. Apolipoprotein A-I transgene corrects apolipoprotein E deficiency-induced atherosclerosis in mice. J. Clin. Invest. 94:899-903.
30. Liu, A.C., Lawn, R.M., Verstuyft, J.G., and Rubin, E.M. 1994. Human apolipoprotein A-I prevents atherosclerosis associated with apolipoprotein[a] in transgenic mice. J. Lipid Res. 35:2263-2267.
31. Nielsen, L.B., et al. 1997. Human apolipoprotein B transgenic mice generated with 207- and 145-kilobase pair bacterial artificial chromosomes. Evidence that a distant 5′-element confers appropriate transgene expression in the intestine. J. Biol. Chem. 272:29752-29758.
32. Paigen, B., Morrow, A., Brandon, C., Mitchell, D., and Holmes, P. 1985. Variation in susceptibility to atherosclerosis among inbred strains of mice. Atherosclerosis. 57:65-73.
33. Paigen, B., Morrow, A., Holmes, P.A., Mitchell, D. and Williams, R.A. 1987. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68:231-240.
34. Paigen, B., Albee, D., Holmes, P.A., and Mitchell, D. 1987. Genetic analysis of murine strains C57BL/6J and C3H/HeJ to confirm the map position of Ath-1, a gene determining atherosclerosis susceptibility. Biochem. Genet. 25:501-511.
35. Reddick, R.L., Zhang, S.H., and Maeda, N. 1994. Atherosclerosis in mice lacking apo E: evaluation of lesional development and progression. Arterioscler. Thromb. 14:141-147.
36. Zhang, S.H., Reddick, R.L., Piedrahita, J.A., and Maeda, N. 1992. Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:468-471.
37. Nakashima, Y., Plump, A.S., Raines, E.W., Breslow, J.L., and Ross, R 1994. Apo E-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler. Thromb. 14:133-140.
38. Tangirala, R.K., Rubin, E.M., and Palinski, W. 1995. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice. J. Lipid Res. 36:2320-2328.
39. Sniderman, A., et al. 1980. Association of coronary atherosclerosis with hyperapobetalipoproteinemia: increased protein but normal cholesterol levels in human plasma low density (β) lipoproteins. Proc. Natl. Acad. Sci. USA. 77:604-608.
40. Teng, B., Sniderman, A.D., Soutar, A.K., and Thompson, G.R. 1986. Metabolic basis of hyperapobetalipoproteinemia: turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia. J. Clin. Invest. 77:663-672.
41. Sniderman, A., Brown, B.C., Stewart, B.F., and Cianflone, K. 1992. From familial combined hyperlipidemia to hyperapoB: unravelling the overproduction of hepatic apolipoprotein B. Curr. Opin. Lipidol. 3:137-142.
42. Callow, M.J., Verstuyft, J., Tangirala, R., Palinski, W., and Rubin, E.M. 1995. Atherogenesis in transgenic mice with human apolipoprotein B and lipoprotein (a). J. Clin. Invest. 96:1639-1646.
43. Goldberg, I.J. 1996. Lipoprotein lipase and lipolysis central roles in lipoprotein metabolism and atherogenesis. J. Lipid Res. 37:693-707.
44. Ylä-Herttuala, S., et al. 1991. Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA. 88:10143-10147.
45. Pattison J.M., Nelson, P.J., Huie, P., Sibley, R.K., and Krensky, A.M. 1996. RANTES chemokine expression in transplant-associated accelerated atherosclerosis. J. Heart Lung Transplant. 15:1194-1199.
46. Russell, M.E., et al. 1993. Early and persistent induction of monocyte chemoattractant protein 1 in rat cardiac allografts. Proc. Natl. Acad. Sci. USA. 90:6086-6090.